News Wire ~ 3rd Party Press Release
COUR Announces First In-Human Dosing in Proof-of-Concept Trial of CNP-201 to Treat Peanut Allergy
CNP-201 is a nanoparticle containing peanut protein that aims to eliminate allergic responses.
That’s it. Launches Video Series Created to Increase Nutrition Education in Children
Smart Apple Academy is a video series featuring five different lessons on childhood nutrition and wellness.
The Worldwide Teal Pumpkin Project is Back to Help Children With Food Allergies Participate...
As the First Ever Title Sponsor, Allergy Insider is Extending the Project Even Further to Guide More Trick-or-Treaters to a Safe Holiday.
For 20 Top-Selling Drugs, Big Pharma Made Far More From US Sales Than From...
Medicare Drug Negotiation Would Help End Disparities
For Immediate Release:Sept. 30, 2021
WASHINGTON, D.C. – U.S. sales of the 20 top-selling drugs totaled $101.1 billion in 2020,...
FARE Announces CEO Lisa Gable to Step Down Effective May 2022
Board launches successor search in interim.
Researcher Wins Grant to Study Impact of Maternal Antibody on Development of Food Allergies...
Grant will help tackle early infant morbidity due to increasing incidences of food allergy.
Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts after 2 Years...
Safety and efficacy increased over time with treatment.
Second COVID-19 mRNA Vaccine Dose Found Safe Following Allergic Reactions to First Dose
Among individuals who had an allergic reaction to their first mRNA COVID-19 vaccine dose, all who went on to receive a second dose tolerated it.
“Supernanny” Jo Frost Calls for Support of Elijah’s Law Nationally
Jo Frost shares a heartfelt message and Call To Action support video.
Study Will Determine Whether Whooping Cough Vaccine Can Help Prevent Food Allergies
"We hope that by training the immune system in this way we will stop it mistakenly mounting allergic responses to harmless substances.”
